CLOVER BIOPHARMACEUTICALS
Clover Biopharmaceuticals is a global, clinical-stage, research-based biotechnology company focused on discovering, developing and commercializing transformative biologic therapies, with a focus on oncology and autoimmune diseases. Clover is utilizing its proprietary Trimer-Tag© technology platform to develop novel biologics targeting trimerization-dependent pathways. Additionally, Clover is leveraging its in-house cGMP biomanufacturing capabilities to develop select biosimilars.
CLOVER BIOPHARMACEUTICALS
Industry:
Biotechnology Clinical Trials Health Care Pharmaceutical
Founded:
2007-01-01
Address:
Chengdu, Sichuan, China
Country:
China
Website Url:
http://www.cloverbiopharma.com
Total Employee:
251+
Status:
Active
Contact:
+86 (028)85336933
Email Addresses:
[email protected]
Total Funding:
343.65 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Mobile Non Scaleable Content Euro IPv6 ReCAPTCHA COVID-19 ReCAPTCHA V2 Java EE Akamai Hosted
Current Employees Featured
Founder
Stock Details
Investors List
Oceanpine Capital
Oceanpine Capital investment in Series C - Clover Biopharmaceuticals
Temasek Holdings
Temasek Holdings investment in Series C - Clover Biopharmaceuticals
OrbiMed
OrbiMed investment in Series C - Clover Biopharmaceuticals
Delos Capital
Delos Capital investment in Series C - Clover Biopharmaceuticals
GL Ventures
GL Ventures investment in Series C - Clover Biopharmaceuticals
GL Ventures
GL Ventures investment in Series B - Clover Biopharmaceuticals
Beida Biomedical Industry Fund
Beida Biomedical Industry Fund investment in Series B - Clover Biopharmaceuticals
Lapam Capital
Lapam Capital investment in Series B - Clover Biopharmaceuticals
Sichuan Province Healthy Pension Industry Equity Investment Fund
Sichuan Province Healthy Pension Industry Equity Investment Fund investment in Series B - Clover Biopharmaceuticals
Zhongguancun VC Development Center
Zhongguancun VC Development Center investment in Series B - Clover Biopharmaceuticals
Key Employee Changes
| Date | New article |
|---|---|
| 2022-06-30 | Clover Announces Executive Leadership Appointments |
Official Site Inspections
http://www.cloverbiopharma.com Semrush global rank: 4.37 M Semrush visits lastest month: 2.58 K
- Host name: 139.196.184.175
- IP address: 139.196.184.175
- Location: Hangzhou China
- Latitude: 30.294
- Longitude: 120.1619
- Timezone: Asia/Shanghai
More informations about "Clover Biopharmaceuticals"
Clover Biopharmaceuticals | Our Company
Bringing innovative vaccines to populations worldwide. With integrated research and development, manufacturing, and commercial capabilities as well as strong partnerships with organizations globally, we have developed a diverse pipeline …See details»
Clover Biopharmaceuticals | Home
Our mission is to leverage our Trimer-Tag technology and in-house manufacturing capabilities for the discovery, development and delivery of innovative and affordable medical solutions.See details»
Clover Announces Corporate Updates and Full Year ... - Clover …
[email protected]. Elaine Qiu Director, Investor Relations. [email protected]. 1 Compound annual growth rate (CGAR) based on …See details»
Clover Biopharmaceuticals - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number +86 (028)85336933 Clover Biopharmaceuticals is a global, clinical-stage, research-based biotechnology company …See details»
Clover Biopharmaceuticals - Overview, News & Similar ... - ZoomInfo
Clover Biopharmaceuticals contact info: Phone number: (866) 901-3295 Website: www.cloverbiopharma.com What does Clover Biopharmaceuticals do? Clover …See details»
CEPI expands partnership with Clover Biopharmaceuticals to …
In addition to CEPI's partnership with Clover, the organization has provided support and funding to develop COVID-19 vaccine candidates to CureVac, Inc., ... For more information, please …See details»
Clover Biopharmaceuticals - Craft
Clover Biopharmaceuticals has 5 employees across 5 locations and $306.71 m in total funding,. See insights on Clover Biopharmaceuticals including office locations, competitors, revenue, …See details»
Clover Biopharmaceuticals Announces Formation of a Global …
Sep 25, 2020 Clover Biopharmaceuticals Contact: Cindy Min Vice President, Public Affairs [email protected] +86 010-82022601 Media Contact: Alison Chen LifeSci …See details»
Clover and GSK announce research collaboration to evaluate …
Feb 24, 2020 [email protected]. Cautionary statement regarding forward-looking statements GSK cautions investors that any forward-looking statements or projections …See details»
Clover Biopharmaceuticals | Our Leadership
Clover Biopharmaceuticals' leadership team, board of directors, global COVID-19 vaccine scientific advisory board and corporate advisory board.See details»
Clover Biopharmaceuticals Receives Pharmaceutical Manufacturing …
Sep 9, 2021 Clover Biopharmaceuticals Receives Pharmaceutical Manufacturing Permit from Zhejiang Medical Products Administration to Produce COVID-19 VaccineSee details»
Clover’s COVID-19 Vaccine Candidate Receives European Union …
SHANGHAI, China, Sept. 20, 2022 (GLOBE NEWSWIRE) -- Clover Biopharmaceuticals, Ltd. (Clover; HKEX: 02197), a global clinical-stage biotechnology company developing novel …See details»
Cytiva supports Clover Biopharmaceuticals to scale up the output …
Nov 16, 2020 For more information, please visit our website: www.cloverbiopharma.com. About Cytiva. Cytiva is a global life sciences leader with more than 7,000 associates across 40 …See details»
Clover’s Universal COVID-19 Booster Vaccine Candidate …
Sep 19, 2022 SHANGHAI, China, Sept. 20, 2022 (GLOBE NEWSWIRE) -- Clover Biopharmaceuticals, Ltd. (Clover; HKEX: 02197), a global clinical-stage biotechnology …See details»
Clover Biopharmaceuticals | Our Culture
A company is its people. We are proud of our community and excited to share it with you. At Clover, you can leverage the organization's global collective of subject matter experts and …See details»
Clover’s Bivalent COVID-19 Vaccine Candidate Demonstrates …
In the pre-clinical study, the bivalent COVID-19 vaccine candidate was comprised of the trimeric spike proteins from the original strain (SCB-2019) and the Omicron variant (SCB-2022B).See details»
Clover Biopharmaceuticals Completes Enrollment of Adult and …
Jul 6, 2021 For more information, please visit our website: www.cloverbiopharma.com and follow the company on LinkedIn. Clover Forward-looking Statements .See details»
Clover Biopharmaceuticals' COVID-19 vaccine study underway
Jul 7, 2021 Chinese clinical-stage biotech Clover Biopharmaceuticals. [Photo/cloverbiopharma.com] Clover Biopharmaceuticals, a global clinical-stage biotechnology …See details»
Clover Biopharmaceuticals | Vaccines
COVID-19 is a disease and global pandemic caused by infection with the SARS-CoV-2 virus. Since March 2020, when the World Health Organization declared COVID-19 a pandemic, …See details»
Clover Biopharmaceuticals' COVID-19 vaccine study underway
Oct 31, 2024 Clover Biopharmaceuticals, a global clinical-stage biotechnology company, announced on Tuesday the completion of targeted enrollment of adult and elderly participants …See details»